BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

306 related articles for article (PubMed ID: 9674752)

  • 21. Generation of dendritic cells from adherent cells of cord blood by culture with granulocyte-macrophage colony-stimulating factor, interleukin-4, and tumor necrosis factor-alpha.
    Zheng Z; Takahashi M; Narita M; Toba K; Liu A; Furukawa T; Koike T; Aizawa Y
    J Hematother Stem Cell Res; 2000 Aug; 9(4):453-64. PubMed ID: 10982243
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Differential effects of autologous serum on CD34(+) or monocyte-derived dendritic cells.
    Loudovaris M; Hansen M; Suen Y; Lee SM; Casing P; Bender JG
    J Hematother Stem Cell Res; 2001 Aug; 10(4):569-78. PubMed ID: 11522239
    [TBL] [Abstract][Full Text] [Related]  

  • 23. A two-step culture method starting with early growth factors permits enhanced production of functional dendritic cells from murine splenocytes.
    Berthier R; Martinon-Ego C; Laharie AM; Marche PN
    J Immunol Methods; 2000 May; 239(1-2):95-107. PubMed ID: 10821951
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Dendritic cells support hematopoiesis of bone marrow cells.
    Wang Q; Zhang W; Ding G; Sun L; Chen G; Cao X
    Transplantation; 2001 Sep; 72(5):891-9. PubMed ID: 11571456
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Functional analysis of human hematopoietic repopulating cells mobilized with granulocyte colony-stimulating factor alone versus granulocyte colony-stimulating factor in combination with stem cell factor.
    Hess DA; Levac KD; Karanu FN; Rosu-Myles M; White MJ; Gallacher L; Murdoch B; Keeney M; Ottowski P; Foley R; Chin-Yee I; Bhatia M
    Blood; 2002 Aug; 100(3):869-78. PubMed ID: 12130497
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Stem cell factor augments tumor necrosis factor-granulocyte-macrophage colony-stimulating factor-mediated dendritic cell hematopoiesis.
    Santiago-Schwarz F; Rappa DA; Laky K; Carsons SE
    Stem Cells; 1995 Mar; 13(2):186-97. PubMed ID: 7540472
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Effective ex vivo generation of granulopoietic postprogenitor cells from mobilized peripheral blood CD34(+) cells.
    Scheding S; Meister B; Bühring HJ; Baum CM; Mc Kearn JP; Bock T; Kanz L; Brugger W
    Exp Hematol; 2000 Apr; 28(4):460-70. PubMed ID: 10781904
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Selective in vivo mobilization with granulocyte macrophage colony-stimulating factor (GM-CSF)/granulocyte-CSF as compared to G-CSF alone of dendritic cell progenitors from peripheral blood progenitor cells in patients with advanced breast cancer undergoing autologous transplantation.
    Avigan D; Wu Z; Gong J; Joyce R; Levine J; Elias A; Richardson P; Milano J; Kennedy L; Anderson K; Kufe D
    Clin Cancer Res; 1999 Oct; 5(10):2735-41. PubMed ID: 10537336
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Surface expression of HLA-DM on dendritic cells derived from CD34-positive bone marrow haematopoietic stem cells.
    Min YH; Lee ST; Choi KM; Hahn JS; Ko YW
    Br J Haematol; 2000 Aug; 110(2):385-93. PubMed ID: 10971396
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Flt3 ligand promotes myeloid dendritic cell differentiation of human hematopoietic progenitor cells: possible application for cancer immunotherapy.
    Harada S; Kimura T; Fujiki H; Nakagawa H; Ueda Y; Itoh T; Yamagishi H; Sonoda Y
    Int J Oncol; 2007 Jun; 30(6):1461-8. PubMed ID: 17487367
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Peripheral blood CD34+ cells differ from bone marrow CD34+ cells in Thy-1 expression and cell cycle status in nonhuman primates mobilized or not mobilized with granulocyte colony-stimulating factor and/or stem cell factor.
    Donahue RE; Kirby MR; Metzger ME; Agricola BA; Sellers SE; Cullis HM
    Blood; 1996 Feb; 87(4):1644-53. PubMed ID: 8608259
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Dendritic cell-based vaccines in the setting of peripheral blood stem cell transplantation: CD34+ cell-depleted mobilized peripheral blood can serve as a source of potent dendritic cells.
    Choi D; Perrin M; Hoffmann S; Chang AE; Ratanatharathorn V; Uberti J; McDonagh KT; Mulé JJ
    Clin Cancer Res; 1998 Nov; 4(11):2709-16. PubMed ID: 9829733
    [TBL] [Abstract][Full Text] [Related]  

  • 33. In vitro generation of dendritic cells derived from cryopreserved CD34+ cells mobilized into peripheral blood in lymphoma patients.
    Enomoto M; Nagayama H; Sato K; Xu Y; Asano S; Takahashi TA
    Cytotherapy; 2000; 2(2):95-104. PubMed ID: 12042046
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Large-scale production and directed induction of functional dendritic cells ex vivo from serum-free expanded human hematopoietic stem cells.
    Hsu SC; Lu LC; Chan KY; Huang CH; Cheng SL; Chan YS; Yang YS; Lai YT; Yao CL
    Cytotherapy; 2019 Jul; 21(7):755-768. PubMed ID: 31105040
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Replicative response, immunophenotype, and functional activity of monocyte-derived versus CD34(+)-derived dendritic cells following exposure to various expansion and maturational stimuli.
    Chen B; Stiff P; Sloan G; Kash J; Manjunath R; Pathasarathy M; Oldenburg D; Foreman KE; Nickoloff BJ
    Clin Immunol; 2001 Feb; 98(2):280-92. PubMed ID: 11161986
    [TBL] [Abstract][Full Text] [Related]  

  • 36. IL-4 and CD40 ligation affect differently the differentiation, maturation, and function of human CD34+ cell-derived CD1a+CD14- and CD1a-CD14+ dendritic cell precursors in vitro.
    Canque B; Camus S; Yagello M; Gluckman JC
    J Leukoc Biol; 1998 Aug; 64(2):235-44. PubMed ID: 9715264
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Comparison of retroviral transduction efficiency in CD34+ cells derived from bone marrow versus G-CSF-mobilized or G-CSF plus stem cell factor-mobilized peripheral blood in nonhuman primates.
    Hematti P; Tuchman S; Larochelle A; Metzger ME; Donahue RE; Tisdale JF
    Stem Cells; 2004; 22(6):1062-9. PubMed ID: 15536196
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Generation of immunostimulatory dendritic cells from human CD34+ hematopoietic progenitor cells of the bone marrow and peripheral blood.
    Bernhard H; Disis ML; Heimfeld S; Hand S; Gralow JR; Cheever MA
    Cancer Res; 1995 Mar; 55(5):1099-104. PubMed ID: 7532543
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Efficient retrovirus-mediated gene transfer of dendritic cells generated from CD34+ cord blood cells under serum-free conditions.
    Bello-Fernandez C; Matyash M; Strobl H; Pickl WF; Majdic O; Lyman SD; Knapp W
    Hum Gene Ther; 1997 Sep; 8(14):1651-8. PubMed ID: 9322867
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Infusion of unpulsed dendritic cells derived from granulocyte/macrophage colony-stimulating factor-mobilized peripheral blood CD34+ cells and monocytes in patients with advanced carcinoma.
    Triozzi PL; Kim J; Aldrich W
    J Hematother Stem Cell Res; 2003 Jun; 12(3):279-87. PubMed ID: 12857369
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 16.